SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Markovits Joel
(Last) (First) (Middle)
C/O RELIANCE GLOBAL GROUP, INC.
300 BLVD. OF THE AMERICAS, SUITE 105
(Street)
LAKEWOOD NJ 08701
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Reliance Global Group, Inc. [ RELI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2024 F(1) 8 D $3.6 10,828 D
Common Stock 09/04/2024 F(1) 9 D $2.67 10,819 D
Common Stock 10/02/2024 F(1) 9 D $2.36 10,810 D
Common Stock 11/01/2024 F(1) 10 D $2.38 10,800 D
Common Stock 11/22/2024 S 10,603 D $1.374 197 D
Common Stock 12/02/2024 F(1) 12 D $1.54 185 D
Common Stock 01/02/2025 F(1) 10 D $2.89 175 D
Common Stock 01/21/2025 A 185,221(2) A $0 185,396 D
Common Stock 02/04/2025 F(3) 16,537 D $1.9566 168,859 D
Common Stock 02/05/2025 A 49,000(4) A $0 217,859 D
Common Stock 02/07/2025 F(3) 17,056 D $1.8815 200,803 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the payment of tax liability by delivering securities incident to the receipt of a previously reported stock grant, which was issued in accordance with Rule 16b-3. This transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
2. Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 37,045 shares on January 27, 2025; and (ii) with respect to 37,044 shares on each of February 3, 2025, July 15, 2025, July 30, 2025, and August 15, 2025.
3. Represents the payment of tax liability incident to the receipt of the January 21, 2025 stock grant, which was issued in accordance with Rule 16b-3 pursuant to the Exchange Act. This transaction is exempt from Section 16(b) of the Exchange Act.
4. Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 16,334 shares on August 30, 2025; and (ii) with respect to 16,333 shares on each of September 15, 2025, and September 30, 2025.
/s/ Joel Markovits 02/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Reliance Global (NASDAQ:RELIW)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Reliance Global Charts.
Reliance Global (NASDAQ:RELIW)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Reliance Global Charts.